Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AYZ | Ann: Removal from Official List | 27/11/19 | 0 | 508 | |||
|
|||||||
AYZ | Ann: Delisting of the Company | 27/11/19 | 0 | 1.2K | |||
|
|||||||
AYZ | Ann: Net Tangible Asset Backing | 14/11/19 | 0 | 420 | |||
|
|||||||
AYZ | Ann: Proxy Form | 28/10/19 | 0 | 338 | |||
|
|||||||
AYZ | Ann: Notice of Annual General Meeting | 28/10/19 | 0 | 412 | |||
|
|||||||
AYZ | Ann: Net Tangible Asset Backing | 14/10/19 | 0 | 376 | |||
|
|||||||
AYZ | Ann: Suspension from Official Quotation | 25/09/19 | 0 | 1.1K | |||
|
|||||||
AYZ | Ann: Capital Return and Dividend Announcement | 15:28 | 0 | 449 | |||
|
See All Discussions